June 2023 - Page 3 of 3 - BioMedWire (BMW)

ThursdayJun 08, 2023 2:46 pm

Scientists Close to Treating Hearing Loss Using Gene Therapy

Around 24.5 million people in the United States, aged 12 years and older, suffer from mild hearing loss while 10.7 million people 12 years and older live with moderate hearing loss. Up to 1.8 million people older than 11 years in the country suffer from moderate hearing loss while more than 400 million people worldwide have some degree of hearing loss. Although there is currently no cure for age-related hearing loss, people can use listening devices, such as hearing aids, to reduce the severity of the condition. In most cases, most of these people suffer from sensorineural hearing loss, which…

WednesdayJun 07, 2023 1:47 pm

Scientists Create Open-Source Platform to Analyze Brain Tumors in Kids

Every year, around 2,200 children and adolescents in the United States receive brain tumor diagnoses. Brain tumors rarely occur in these age groups, and most children and adolescents diagnosed with brain tumors grow into adulthood. However, even though pediatric brain tumors are relatively rare, they are among the leading causes of death in children in the country. Furthermore, even less deadly brain tumor variants with longer survival rates negatively affect the diagnosed children and their families. As such, researchers are constantly working on better diagnosing, analyzing and treating brain tumors to improve treatment outcomes even further. Recent efforts by a…

TuesdayJun 06, 2023 3:07 pm

New Computational Platform to Broaden Options of Potential Immunotherapy Targets in Cancer Treatment

Immunotherapy is a relatively novel way of treating cancer. It entails boosting one’s immune system so it can locate and destroy cancer cells. This type of treatment is typically recommended for patients suffering from cases of advanced cancer, and it can be used to address conditions such as kidney cancer, lymphoma, bladder cancer and non-small cell lung cancer. Since immunotherapy has only been around since the 1980s, researchers and clinicians are constantly working to make the treatment safer and more effective for cancer patients. A team of researchers from UCLA and the Children’s Hospital of Philadelphia (CHOP) have now created…

MondayJun 05, 2023 1:59 pm

Why Healthcare Should Adopt Merchandising Practices

Healthcare has gone through several evolutions throughout the course of human history. Our first attempts at treating medical conditions were half-hearted at best and hampered by our ignorance of germ theory and human biology. The acceptance of germ theory paved the way for modern healthcare and allowed humanity to treat previously fatal injuries and conditions, extending our lifetimes and giving people much longer lifespans. The medical field continued to develop in tandem with technology, adapting more and more complex technology into the field to enhance research and develop a wide variety of medications. With the internet and e-commerce now entrenched…

FridayJun 02, 2023 11:50 am

Initial Evidence Suggests Possible Link Between COVID-19, Tinnitus

The coronavirus pandemic threw the entire world into a lurch and showed us just how difficult it can be to deal with a pandemic in our increasingly connected world. A few months after the virus was first discovered in Wuhan, China, dozens of countries shut down their borders to stop the disease from spreading at the cost of economic activity. The coronavirus vaccine appears to have been instrumental in stopping COVID-19 infections, reducing negative health outcomes and opening up the world to international activity once again. However, although we are now through the worst of the pandemic, infections are still…

FridayJun 02, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Displays CDMO Expertise at Prestigious Biomed Israel Conference

Biotechnology innovator BiondVax Pharmaceuticals is dedicated to developing nanosized antibody (NanoAb) treatment BiondVax is also leveraging its team experience in preclinical stage to Phase 3 clinical trial product development to generate new revenues by offering cGMP contract development and manufacturing organization (“CDMO”) services The company recently exhibited its CDMO expertise as well as its NanoAb development pipeline at the 21st annual Biomed Israel conference, which drew over 6,000 attendees from a wide variety of international life sciences disciplines BiondVax’s NanoAb drug candidate pipeline has expanded focus on immune system cytokine targets for treating psoriasis and psoriatic arthritis Israel-based biotechnology company…

FridayJun 02, 2023 9:15 am

Genprex Inc.’s (NASDAQ: GNPX) Inspiring Patient Video on Gene Therapy’s Potential in NSCLC Treatment

Gene Therapy's Transformative Potential Highlighted in Inspiring Patient Video Interview with Genprex’s (NASDAQ: GNPX) REQORSA on Benzinga. Click Here for the full article The interview showcases the real-life experience of a patient participating in a clinical trial utilizing Genprex's innovative gene therapy drug candidate, REQORSA, shedding light on the significant impact it could potentially have in advancing the treatment of non-small cell lung cancer. The featured video highlights the compelling story of Jacqueline Marino, a participant in the Phase 1 segment of Genprex's Phase 1/2 Acclaim-1 clinical trial. Marino, diagnosed with non-small cell lung cancer (“NSCLC”), offers an inspiring account…

ThursdayJun 01, 2023 11:54 am

Study Shows Brain Cancer Among Top Cancer Types in US

Prior studies have indicated that brain cancer occurs with more frequency in Northern Europe, North America and Australia with Russia, India, the United States, China and Brazil having the highest brain tumor mortality rates. There has also been a significant increase in global brain and central nervous system cancer rates over the past few decades, with the number of cases surging by 94.35% from 1990 to 2019. A new study has now revealed that brain tumors are the fifth most common type of cancer in the nation. These tumors often occur as a result of a growth of abnormal cells…